Wardwizard Healt

Why is Wardwizard Healthcare Ltd falling/rising?

As of 23-Jun, Wardwizard Healthcare Ltd's stock price is Rs. 43.19, having reached a new 52-week and all-time high today. The stock has shown strong upward momentum, outperforming its sector and demonstrating significant gains over the past year despite some erratic trading.

As of 23-Jun, Wardwizard Healthcare Ltd's stock price is rising. The current price is Rs. 43.19, which represents a change of 0.00 (0.00%) as of 09:10 PM. Notably, the stock reached a new 52-week and all-time high of Rs. 43.19 today, indicating strong upward momentum. <BR><BR>The stock opened with a gain of 4.98% and touched an intraday high of Rs. 43.19, reflecting positive trading activity. Additionally, it has outperformed its sector by 4.88%. The stock is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator suggesting sustained upward price movement. <BR><BR>Despite some erratic trading, with the stock not trading on 5 out of the last 20 days, the overall performance over the past year shows an impressive increase of 88.11%, while the broader Sensex has declined by 6.96% in the same period. This strong relative performance further supports the stock's rising trend.

Which are the latest news on Wardwizard Healt?

What does Wardwizard Healt do?

Wardwizard Healthcare Ltd, formerly Ayoki Merchantile Limited, operates in the Trading & Distributors industry as a Micro Cap company, reporting net sales of 1 Cr and no net profit for the quarter ending March 2026. The company has a market cap of INR 1 Cr and no debt or dividend yield.

Overview: <BR>Wardwizard Healthcare Ltd operates in the Trading & Distributors industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The company was incorporated in 1985 as 'Ayoki Merchantile Limited' and changed its name to 'Wardwizard Healthcare Limited' on December 11, 2023. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 1 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00<BR><BR>Contact Details: <BR>Address: Laxmi Commercial Centre 4th Fr, Room No 405 S B Marg Dadar(W) Mumbai Maharashtra : 400028 <BR>Tel: 91-22-24219195/32435510 <BR>Email: ayokimerchantile@gmail.com <BR>Website: http://www.ayokimerchantile.com

How big is Wardwizard Healt?

As of 10th June, Wardwizard Healthcare Ltd has a market capitalization of 1.00 Cr and reported net sales of 0.84 Cr with a net profit loss of 0.31 Cr over the last four quarters. Shareholder's funds are at a loss of 3.11 Cr, with total assets valued at 8.62 Cr.

As of 10th June, <BR><BR>Market Cap: Wardwizard Healthcare Ltd has a market capitalization of 1.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.84 Cr, while the sum of Net Profit for the same period reflects a loss of 0.31 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds stand at a loss of 3.11 Cr, and Total Assets are valued at 8.62 Cr.

Who are in the management team of Wardwizard Healt?

The management team of Wardwizard Healt includes Gouranga Lal Kundu (Company Secretary), Joydeep Mazumder (Managing Director), and several independent and additional directors such as Ankita Chanda and Souvik Bose. For more details on specific members, please ask!

The management team of Wardwizard Healt includes the following individuals:<BR><BR>1. **Gouranga Lal Kundu** - Company Secretary<BR>2. **Ankita Chanda** - Additional Independent Director<BR>3. **Souvik Bose** - Independent Director<BR>4. **Joydeep Mazumder** - Managing Director<BR>5. **Munmun Mandal** - Director<BR>6. **Adipta Majumder** - Additional Independent Director<BR>7. **Subhendu Saha** - Additional Director<BR>8. **Dipankar Majumder** - Independent Director<BR>9. **Dharmesh Chauhan** - Company Secretary & Compliance Officer<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

Who are the peers of the Wardwizard Healt?

Wardwizard Healt's peers are Modella Woollens, Beeyu Overseas, and Diksha Greens, all of which show management and growth risks, as well as weak capital structures. Wardwizard Healt outperforms its peers significantly, with a 1-year return of 97.49%, while Diksha Greens has the lowest return at -58.36%.

Peers: The peers of Wardwizard Healt are Modella Woollens, Beeyu Overseas, and Diksha Greens.<BR><BR>Quality Snapshot: All peers exhibit a management risk that does not qualify, indicating a lack of excellent management risk across the board. Similarly, growth does not qualify for Modella Woollens, Beeyu Overseas, and Diksha Greens, suggesting that none of these companies are currently positioned for growth. Furthermore, the capital structure does not qualify for any of the peers, which highlights a common weakness in financial stability among them.<BR><BR>Return Snapshot: Diksha Greens has the lowest 1-year return at -58.36%, while Wardwizard Healt boasts the highest at 97.49%. This indicates a significant performance gap, with Wardwizard Healt outperforming its peers. Additionally, Modella Woollens, Beeyu Overseas, and Diksha Greens all have negative six-month returns.

How has been the historical performance of Wardwizard Healt?

Wardwizard Healt has consistently reported no profit or cash flow from 2018 to 2024, with profit before tax and cash flow remaining at 0.00 Rs cr for multiple years, indicating stagnant financial performance.

Answer:<BR>The historical performance of Wardwizard Healt shows a consistent lack of profit and cash flow across multiple years.<BR><BR>Breakdown:<BR>Wardwizard Healt has reported a profit before tax of 0.00 Rs cr for the years ending March 2024, 2023, 2022, 2020, 2019, and 2018, indicating no profitability during this period. Adjustments and changes in working capital also remained at 0.00 Rs cr for the same years, with a minor adjustment of -0.01 Rs cr in March 2018 and a slight increase of 0.01 Rs cr in working capital in the same year. Cash flow after changes in working capital was consistently 0.00 Rs cr from March 2024 to March 2022, with a small positive cash flow of 0.01 Rs cr in March 2018. Cash flow from operating and investing activities remained at 0.00 Rs cr for the years ending March 2024 to March 2022, while there was a cash inflow of 0.07 Rs cr from investing activities in March 2018. The net cash inflow/outflow was also 0.00 Rs cr for the years 2024 to 2022, with a closing cash and cash equivalent of 0.00 Rs cr in March 2024, 2023, and 2022, and a slight increase to 0.10 Rs cr in March 2018. Overall, the data reflects a stagnant financial performance with no significant changes in cash flow or profitability over the years.

Who are the top shareholders of the Wardwizard Healt?

The top shareholder of Wardwizard Healt is Yatin Sanjay Gupte, holding 37.04%, with no pledged promoter holdings. The highest public shareholder is Shiva Avdheshratan Dubey at 5.35%, and individual investors collectively own 18.52% of the shares.

The top shareholders of Wardwizard Healt include the promoters, with Yatin Sanjay Gupte holding the largest share at 37.04%. There are no pledged promoter holdings, and the company currently has no mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Shiva Avdheshratan Dubey, who owns 5.35%. Additionally, individual investors collectively hold 18.52% of the company's shares.

When is the next results date for Wardwizard Healt?

No Upcoming Board Meetings